Clinical Track Poster Presentation: PPK and Exposure-Response Evaluation of Nivolumab in Combination with Chemotherapy as First Line Treatment in Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction or Esophageal Adenocarcinoma

Authors: Ludwig E
Keywords: MIDD (model-informed drug development), MIDD+ 2023, modeling and simulation, SLP MIDD+ Virtual Conference, SLP2023MIDD
Division: Simulations Plus

Presented by Elizabeth Ludwig at MIDD+ 2023 on Wednesday, February 15th.

Session Moderator: Tom Sun

Download slides